These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3678300)

  • 1. Treatment of invasive grade 3 transitional cell bladder cancer. A retrospective study of 10 years' experience with external irradiation, and preoperative irradiation and cystectomy.
    Wijkström H; Edsmyr F; Nilsson B
    Eur Urol; 1987; 13(5):300-4. PubMed ID: 3678300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated preoperative irradiation and radical cystectomy.
    Sagerman RH; Yu WS; Ryoo MC; King GA; Chung CT; Emmanuel IG
    Int J Radiat Oncol Biol Phys; 1980 May; 6(5):607-12. PubMed ID: 7410137
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
    Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
    Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.
    Smith JA; Crawford ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW
    J Urol; 1997 Mar; 157(3):805-7; discussion 807-8. PubMed ID: 9072571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate.
    Thrasher JB; Frazier HA; Robertson JE; Dodge RK; Paulson DF
    Cancer; 1994 Mar; 73(6):1708-15. PubMed ID: 8156499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
    Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive bladder cancer. Should patients who respond to radiotherapy be treated by cystectomy?
    Langemeyer TN; Peer PG; Janknegt RA; Leers WH
    Br J Urol; 1987 Sep; 60(3):248-51. PubMed ID: 3676671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192.
    Mazeron JJ; Crook J; Chopin D; Abbou CC; Le Bourgeois JP; Auvert J; Pierquin B
    Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1323-30. PubMed ID: 3198436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective bladder preservation by combination treatment of invasive bladder cancer.
    Kaufman DS; Shipley WU; Griffin PP; Heney NM; Althausen AF; Efird JT
    N Engl J Med; 1993 Nov; 329(19):1377-82. PubMed ID: 8413433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
    Sawada Y; Takeuchi Y; Iwasawa T; Kuroda K; Matsushima M; Nagamoto M; Wakayama M
    Int J Urol; 2006 Dec; 13(12):1470-4. PubMed ID: 17118019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of preoperative classification according to the TNM system. A critical examination of Category T2 in 96 patients with grade 3 transitional cell bladder carcinoma subjected to preparative irradiation and cystectomy.
    Wijkström H; Edsmyr F; Lundh B
    Eur Urol; 1984; 10(2):101-6. PubMed ID: 6705815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative irradiation and radical cystectomy for bladder cancer.
    Reid EC; Mount BM; Sullivan N
    Urology; 1973 Jan; 1(1):42-5. PubMed ID: 4792284
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative irradiation in the surgical treatment of transitional cell cancer of the bladder: preliminary report based on 12 years of experience.
    Scott R; Koff WJ; Hudgins PT; McCullough D
    J Urol; 1973 Mar; 109(3):405-8. PubMed ID: 4692374
    [No Abstract]   [Full Text] [Related]  

  • 15. Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin.
    Marks LB; Kaufman SD; Prout GR; Heney NM; Griffin PP; Shipley WU
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):877-83. PubMed ID: 3182328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder.
    Russell KJ; Boileau MA; Higano C; Collins C; Russell AH; Koh W; Cole SB; Chapman WH; Griffin TW
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):693-9. PubMed ID: 2211217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management and outcome of bladder carcinoma in Ontario, 1982-1994.
    Hayter CR; Paszat LF; Groome PA; Schulze K; Mackillop WJ
    Cancer; 2000 Jul; 89(1):142-51. PubMed ID: 10897011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
    Soloway MS; Lopez AE; Patel J; Lu Y
    Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.